Hao Chi Zhang, MD (he/him/his)

University of Texas MD Anderson Cancer Center

Poster(s):

• P6081 - A Strategy Utilizing Tocilizumab, Budesonide, and Mycophenolate Mofetil in the Peri-Operative Period to Achieve Biochemical Remission in High-Grade Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: A Case Study
  Tuesday, October 28, 2025

  10:30 AM - 4:00 PM PDT